Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

3.2K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
3.2K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

3.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

931
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
931

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Convergence and innovative applications of cutting-edge biomedical technologies in brain organoid research.

Experimental neurology·2026
Same author

Translational potential of GMP-grade human umbilical cord-derived mesenchymal stem cells (UC-MSCs) in traumatic spinal cord injury: a preclinical study in rat.

Journal of translational medicine·2026
Same author

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Effects of low-dose methylprednisolone sodium succinate on lung function and blood gas function in elderly patients with chronic obstructive pulmonary disease complicated with respiratory failure.

Pakistan journal of pharmaceutical sciences·2026
Same author

Salmonella Typhimurium hijacks a host glucose transporter for intravacuolar proliferation.

Cell communication and signaling : CCS·2026
Same author

MAIT Cells Maintain Intestinal Homeostasis Through IL-22 in an Experimental Colitis.

Journal of inflammation research·2026
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.8K

Does a natural killer need a CAR?

Kangbo Wang1, Yumo Zhang1, Zhibo Han1

  • 1Institute of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, China.

Frontiers in Immunology
|July 11, 2025
PubMed
Summary
This summary is machine-generated.

Chimeric antigen receptor (CAR) technology is being adapted for natural killer (NK) cells, offering a promising new avenue for cancer immunotherapy. This review examines CAR-NK design, efficacy, and clinical translation potential.

Keywords:
CAR-NK cellsNK cell activationchimeric antigen receptorimmunotherapynatural killer cells

More Related Videos

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

18.9K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

871

Related Experiment Videos

Last Updated: Sep 16, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.8K
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

18.9K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

871

Area of Science:

  • Immunology
  • Oncology
  • Cell Therapy

Background:

  • Chimeric antigen receptor T cell (CAR-T) therapy has shown significant success in treating hematologic malignancies.
  • Natural killer (NK) cells, innate lymphocytes with inherent tumor-killing capabilities, are being explored as a new platform for CAR-based immunotherapy.
  • NK cells offer potential advantages over T cells, including intrinsic cytotoxicity and amenability to expansion for enhanced antitumor responses.

Purpose of the Study:

  • To explore the principles and strategies for designing CARs adapted to NK cell biology.
  • To critically evaluate the necessity of CARs for NK cell function in cancer therapy.
  • To discuss the opportunities and challenges in the clinical translation of CAR-NK therapy.

Main Methods:

  • Review of existing literature on CAR-NK cell therapy.
  • Analysis of NK cell biology and its implications for CAR design.
  • Critical examination of CAR-NK research and clinical trial data.

Main Results:

  • CARs can be adapted for NK cells, leveraging their innate cytotoxic mechanisms.
  • The essentiality of CARs for NK cell function is debated, as NK cells possess intrinsic antitumor activity.
  • CAR-NK therapy presents unique opportunities for cancer treatment but also faces challenges in clinical implementation.

Conclusions:

  • CAR-NK therapy represents a promising advancement in cancer immunotherapy, building upon the success of CAR-T cells.
  • Further research is needed to optimize CAR-NK design and fully understand its therapeutic potential and limitations.
  • Successful clinical translation of CAR-NK therapy requires addressing specific biological and logistical challenges.